These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16214825)

  • 21. Association between adverse effects under azathioprine therapy and inosine triphosphate pyrophosphatase activity in patients with chronic inflammatory bowel disease.
    Shipkova M; Franz J; Abe M; Klett C; Wieland E; Andus T
    Ther Drug Monit; 2011 Jun; 33(3):321-8. PubMed ID: 21544018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutropenia related to an azathioprine metabolic disorder induced by an inosine triphosphate pyrophosphohydrolase (ITPA) gene mutation in a patient with PR3-ANCA-positive microscopic polyangiitis
.
    Honda K; Kobayashi A; Niikura T; Hasegawa T; Saito Z; Ito S; Sasaki T; Komine K; Ishizuka S; Motoi Y; Kubota T; Yamamoto H; Yokoo T
    Clin Nephrol; 2018 Nov; 90(5):363-369. PubMed ID: 30106365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allele frequency of inosine triphosphate pyrophosphatase (ITPA) and thiopurine-S-methyl transferase (TPMT) genes in the Tunisian population.
    Melaouhia S; Fékih M; Garat A; Allorge D; Ferchichi H; Klouz A; Boubaker J; Broly F; Lakhal M
    Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):178-84. PubMed ID: 22225964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
    Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn's disease patients.
    Salazar J; Riera P; Gordillo J; Altès A; Martínez M; Serès M; Llaó J; Giordano A; Garcia-Planella E
    Pharmacogenomics J; 2024 Jun; 24(4):20. PubMed ID: 38906864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe thiopurine-induced leukocytopenia and hair loss in Japanese patients with defective NUDT15 variant: Retrospective case-control study.
    Kishibe M; Nozaki H; Fujii M; Iinuma S; Ohtsubo S; Igawa S; Kanno K; Honma M; Kishibe K; Okamoto K; Ishida-Yamamoto A
    J Dermatol; 2018 Oct; 45(10):1160-1165. PubMed ID: 30101994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases.
    Cheon JH; Kim JH; Kim BY; Kim SW; Hong SY; Eun CS; Hong SS; Byeon JS; Kim TI; Han DS; Yang SK; Lee KR; Kim WH
    Hepatogastroenterology; 2009; 56(90):421-3. PubMed ID: 19579612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ITPA Activity in Children Treated by Azathioprine: Relationship to the Occurrence of Adverse Drug Reactions and Inflammatory Response.
    Citterio-Quentin A; Moulsma M; Gustin MP; Lachaux A; Boulieu R
    Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):588-595. PubMed ID: 29327413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.
    Ansari A; Arenas M; Greenfield SM; Morris D; Lindsay J; Gilshenan K; Smith M; Lewis C; Marinaki A; Duley J; Sanderson J
    Aliment Pharmacol Ther; 2008 Oct; 28(8):973-83. PubMed ID: 18616518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.
    Cuffari C; Dassopoulos T; Turnbough L; Thompson RE; Bayless TM
    Clin Gastroenterol Hepatol; 2004 May; 2(5):410-7. PubMed ID: 15118980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6.
    Atanasova S; Shipkova M; Svinarov D; Mladenova A; Genova M; Wieland E; Oellerich M; von Ahsen N
    Ther Drug Monit; 2007 Feb; 29(1):6-10. PubMed ID: 17304144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis.
    Liu YP; Xu HQ; Li M; Yang X; Yu S; Fu WL; Huang Q
    PLoS One; 2015; 10(12):e0144234. PubMed ID: 26633017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine.
    Wan Rosalina WR; Teh LK; Mohamad N; Nasir A; Yusoff R; Baba AA; Salleh MZ
    J Clin Pharm Ther; 2012 Apr; 37(2):237-41. PubMed ID: 21545474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
    Schwab M; Schäffeler E; Marx C; Fischer C; Lang T; Behrens C; Gregor M; Eichelbaum M; Zanger UM; Kaskas BA
    Pharmacogenetics; 2002 Aug; 12(6):429-36. PubMed ID: 12172211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
    Zhu Q; Cao Q
    Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological monitoring of azathioprine therapy.
    Reuther LO; Sonne J; Larsen NE; Larsen B; Christensen S; Rasmussen SN; Tofteng F; Haaber A; Johansen N; Kjeldsen J; Schmiegelow K
    Scand J Gastroenterol; 2003 Sep; 38(9):972-7. PubMed ID: 14531535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the Association Between the ITPA Gene 94C>A Gene Sequence Variant and Liver Transplant Rejection in Iranian Liver Transplant Recipients.
    Heidari M; Khalili M; Malek Hosseini SA; Geramizadeh B; Shamsaefar AR; Balouchi F; Karimi MH
    Exp Clin Transplant; 2022 Dec; 20(12):1094-1098. PubMed ID: 36718008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine.
    Buster EH; van Vuuren HJ; Zondervan PE; Metselaar HJ; Tilanus HW; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):68-72. PubMed ID: 18090994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.